Industry Reports Services Press Release
  •   Blogs
  • Contact us About us

    Asia Pacific Bioreactors Market Size Forecast 2028 By Cell (Mammalian Cells, Bacterial Cells, Yeast Cells), By Product Type (Single-use, Reusable), By Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy), By End-use (R&D Organizations, Biopharma Manufacturers, CMOs), Research Report, Country Outlook (China, Japan, India, South Korea, Australia, Singapore, Indonesia, Malaysia, Philippines, Thailand), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
    Published Date: November 2022   |   Report ID: GR1234   |   Delivery: PDF  Request Free Sample

    Asia Pacific Bioreactors Market size crossed USD 1.3 billion in 2021 and is anticipated to showcase around 14.5% growth rate between 2022 and 2028.

    Bioreactors offer enormous potential in the development of vaccines & other medicines used to combat the global spread of COVID-19 and other infectious disorders. The increasing requirement from governmental vaccination programs and private entities to vaccine large sections of the population requires scientists to work under pressure to shorten the time-to-market.

    Asia Pacific Bioreactors Market

    Get more details on this report - Request Free Sample PDF

    Innovations in single-use bioreactors will offer momentous growth opportunities to Asia Pacific market. These advancements include remote monitoring of culture process, continuous manufacturing, integration of analytical technology, and single-use systems.

    Impact of COVID-19 outbreak on Asia Pacific bioreactors market outlook

    The COVID-19 pandemic strained global healthcare systems and disrupted the supply chains. It necessitated the development of vaccinations and monoclonal antibodies for the prevention and treatment of the devastating disease, as well as other autoimmune conditions. A large amount of investments are made toward research into cell culture media created in bioreactors. The need for appropriate immunizations and pharmaceutical products is projected to boost the Asia Pacific bioreactors business outlook, as the global threat of infectious and chronic diseases grows.

    Asia Pacific Market, By Product Type

    The Asia Pacific reusable bioreactors market share is expected to be more than 70% by 2028. Reusable stainless-steel bioreactors have fixed vessel configurations with predefined port assemblies. They assist in the production of vaccines and drugs at a larger volume and scale. These bioreactors are increasingly used large-scale production runs in numerous biologics and pharmaceuticals manufacturers and contract manufacturing organizations in nations such as China and India.

    Asia Pacific Market, By Cell

    Mammalian cells are widely used in bioprocessing viral vaccines, medicines, and diagnostic proteins. They are also used in research. The fundamental benefits of mammalian cell expression are that the signals for eukaryotic protein synthesis, processing, and secretion are accurately and effectively recognized. Although antibody production via mammalian cells is more challenging, the main advantage is that the antibody will be as near to native structure as feasible, offering good binding activity.

    Asia Pacific Bioreactors Market, By Cell

    The stem cells segment will exhibit a CAGR of 14% during the forecast period, owing to rising number of research activities to develop stem cell therapy for a wide range of applications including regenerative medicine and aesthetic medicine. The Indian biotech sector grew by 14% with investments in R&D trebling to USD 1.02 billion in 2021 from USD 320 million in 2020, according to a report released by the country’s Department of Biotechnology.

    Asia Pacific Market, By End-use

    Adoption of bioreactors in CMOs will expand during the analysis period. Numerous companies based in the developed countries outsource manufacturing activities to Asian countries owing to cost advantage. With growing need for cost containment, increasing number of CMOs in the region, the demand for bioreactors will surge over the forthcoming years. The presence of major companies in the region will serve to be high impacting factor for product consumption.

    Competitive Industry Landscape

    Major players involved in the Asia Pacific bioreactors market include Cytiva, Sartorius Stedim Biotech, Merck, Eppendorf AG, and Thermo Fisher Scientific. These companies are undertaking various strategies such as product launch and collaborations to strengthen their market position. Catering to the high demand for large-scale single-use systems, Thermo Fisher Scientific announced the launch of HyPerforma DynaDrive 5,000 L and HyPerforma DynaDrive 3,000 L single-use bioreactors in March 2021.

    Frequently Asked Question(FAQ) :

    What is the value of Asia Pacific bioreactors industry?
    The market for bioreactors in Asia Pacific was valued at more than USD 1.3 billion in 2021 and is expected to record a CAGR of more than 14.5% between the forecast years 2022-2028.
    Why are reusable bioreactor sales growing in Asia Pacific?
    Reusable products are expected to hold over 70% share of the market by 2028, with key features such as enabling production of vaccines on a large scale.
    How do CMOs impact bioreactors market in Asia Pacific?
    The industry share for bioreactors in APAC from contract research organizations (CMO) end-users will see significant growth over 2022-2028, with increasing focus on pharmaceutical product and the need for outsourcing of the manufacturing process.
    Which companies operate in Asia Pacific bioreactors landscape?
    Some prominent companies operating in the market include Cytiva, Sartorius Stedim Biotech, Merck, Eppendorf AG, and Thermo Fisher Scientific, among others.

    Get this research report on Asia Pacific Bioreactors Market customized according to your business requirements.

    report-purchase - logo Buy Now

    Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team


     [email protected]